Zeiser, R <br/><br/>
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.  [electronic resource] 

 -  Leukemia  Oct 2015 
 - 2062-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2015.212  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--pharmacology<br/>Adult<br/>Aged<br/>Animals<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Follow-Up Studies<br/>Graft vs Host Disease--drug therapy<br/>Hematologic Neoplasms--complications<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Janus Kinases--antagonists & inhibitors<br/>Male<br/>Mice<br/>Middle Aged<br/>Neoplasm Staging<br/>Nitriles<br/>Prognosis<br/>Pyrazoles--therapeutic use<br/>Pyrimidines<br/>Recurrence<br/>Retrospective Studies<br/>Salvage Therapy<br/>Survival Rate<br/>Transplantation, Homologous<br/>Young Adult